How multiple morphogen signals are coordinated in space and time to position key embryonic tissues remains elusive. During neural crest formation, bone morphogenetic protein (BMP), fibroblast growth factor (FGF) and WNT signaling cooperate by acting either on the paraxial mesoderm or directly on the neural border ectoderm, but how each tissue interprets this complex information remains poorly understood. Here we show that Fhl3, a scaffold LIM domain protein of previously unknown developmental function, is essential for neural crest formation by linking BMP and WNT signaling thereby positioning the neural crest-inducing signaling center in the paraxial mesoderm. During gastrulation, Fhl3 promotes Smad phosphorylation and Smad-dependent wnt8 activation specifically in the paraxial mesoderm, thus modifying the respective mesoderm or ectoderm cell response to the extracellular BMP gradient. This ensures neural border ectoderm specification by the underlying mesoderm via non-cell autonomous WNT signaling. During neurulation, neural crest inducers activate fhl3, promoting BMP/Smad-dependent WNT activity required for neural crest specification. Our findings highlight how Fhl3, acting cell-autonomously, ensures a fine spatial, temporal and germ layer-specific coordination of BMP and WNT signaling at several steps of neural crest development. Keywords: BMP, WNT, four and a half LIM domain protein 3, neural border, paraxial mesoderm, neural crest gene regulatory network, morphogen cross-talk.
Introduction
A strict spatial and temporal control of BMP activity is crucial for both early mesoderm and ectoderm patterning (Bier and De Robertis, 2015) . Additional morphogen gradients further refine the pattern of each germ layer. For instance the cooperation between BMP, FGF and WNT signaling pathways activates neural crest (NC) early development (Garnett et al., 2012) .
How these pathways crosstalk and are integrated into a coherent cell response remains poorly understood either during NC induction by the underlying mesoderm, or during its later specification at the edge of the neural plate ectoderm (NP). NC cells (NCCs) are a multipotent population generating a vast array of derivatives in vertebrates, including neurons, glia, pigment, bone and cartilage (Douarin and Kalcheim, 1999) . The NC is induced from the neural border ectoderm (NB), precisely located lateral to the NP and emerging at early gastrula stage (De Crozé et al., 2011; Plouhinec et al., 2017) . Initiation of the NC gene regulatory network (GRN) during gastrulation involves the response to BMP, WNTs and FGFs activated at precise levels, either in the ectoderm or in the underlying mesoderm, and diffusing towards the future NB. Later on, during neurulation and organogenesis, reiterated BMP and WNT signals control several additional steps of the NC-GRN within the ectoderm (Pla and Monsoro-Burq, 2018) .
While the role of each pathway has been studied separately, potential fine-tuned and tissuespecific cross-regulations between BMP and WNT signaling remain to be understood.
In the gastrula ectoderm, lack of BMP signaling allows neural induction, intermediate levels of BMP signaling are required for NB and NC initiation, while high BMP activity promotes non-neural ectoderm formation (De Robertis and Kuroda, 2004; Faure et al., 2002; LaBonne and Bronner-Fraser, 1998; Luo et al., 2001) . In gastrula mesoderm, paraxial and intermediate progenitors receive moderate BMP activity due to BMP antagonists diffusing from the axial mesoderm (Harland and Gerhart, 1997) . During neurulation, enhanced BMP signaling around the NP is necessary for further NC development (Litsiou et al., 2005; Steventon et al., 2009; Wu et al., 2011) . Therefore, a fine-tuned and dynamic modulation of BMP signaling is particularly critical for positioning the NC, between neural and non-neural ectoderm, and promoting sequential steps of the NC-GRN. BMP ligands bind to membrane receptors triggering intracellular phosphorylation and dimerization of the receptor-regulated (R) Smad1/5/8, and their trimerization with the common (co) Smad4 (Lönn et al., 2009 ). R-Smad/co-Smad complexes regulate target genes transcription in the nucleus, in a BMP dosedependent manner (Massagué et al., 2005) . Numerous extracellular or cytoplasmic regulators of BMP signaling act in various cell contexts (Kuriyama et al., 2006; Schille et al., 2016; Sieber et al., 2009) . During NC development however, apart from SNW1 and SMURF1, two BMP modifiers acting in the neurectoderm (Piacentino and Bronner, 2018; Wu et al., 2011) , little is known about the regulators controlling the intermediate levels of BMP signaling locally early on.
Moreover, modulating BMP signaling to reach intermediate levels of activity is not sufficient to elicit robust NB induction: additional WNT and FGF signals from the mesoderm cooperate with BMPs to activate NB/NC specifier expression in the ectoderm. At the time of NB specification in frog gastrulas, the dorsal-lateral marginal zone (DLMZ), which will form both paraxial and intermediate mesoderm (thereafter collectively called "paraxial mesoderm"), expresses several FGF and WNT ligands diffusing towards the overlying ectoderm. Inhibiting any of these signals prevents NB-NC activation (Chang and Hemmati Brivanlou, 1998; Elkouby et al., 2010; Garnett et al., 2012; Garriock et al., 2007; LaBonne and Bronner-Fraser, 1998; Monsoro-Burq et al., 2003; Saint-Jeannet et al., 1997) .
We found enriched expression of fhl3, encoding an intracellular scaffolding protein, in the developing frog NC and underlying mesoderm. Fhl3 is a four-and-a-half LIM domain protein implicated in protein-protein interactions in adult cells and cancer, with no previously described developmental function (Kadrmas and Beckerle, 2004) . FHL proteins broadly regulate cell proliferation, differentiation and apoptosis (Bach, 2000) . In cancer cells responding to TGFb, Fhl3 interacts with R-Smad2/3 and Smad4 and modulates TGFb signaling in a contextdependent manner (Ding et al., 2009; Han et al., 2018) . During muscle fiber differentiation in vitro, Fhl3 binds to MyoD and to Sox15, resulting in Foxk1 coactivation, increased myoblast proliferation and blocked myotube fusion (Cottle et al., 2007; Meeson et al., 2007) . These studies thus suggest that Fhl3 could modulate both cell signaling or gene transcription.
Here, we find that Fhl3 is a critical enhancer of BMP and WNT signaling during NC early development in vivo, linking the BMP intracellular signaling cascade to wnt8 activation both in the mesoderm and in the neural border ectoderm. Fhl3 cell-autonomous activity allows modulating independently mesoderm or ectoderm cell response to the same extracellular BMP gradient and is essential for the coordinated patterning of dorsal tissues during NC development.
Results

Fhl3 is expressed in the dorsal mesoderm and activated in neural crest cells by Pax3
To get insights into fhl3 function, we analyzed its developmental expression in frogs, compared to patterns of regional markers in the dorsal mesoderm and ectoderm (Figures 1A, S1) . Fhl3 expression appears in the involuting mesoderm of early gastrulas (dorsal marginal zone (DMZ) and DLMZ) and remains in the axial (notochord) and paraxial mesoderm until tailbud stages. Fhl3 is also expressed in the late gastrula NB ectoderm ( Figure S1 ). In midneurula ectoderm, when compared to the NB marker pax3 and the premigratory NC marker snai2, fhl3 is first activated in a subset of cephalic NCCs at hindbrain level. Upon neural tube closure, fhl3 is expressed in all premigratory NCCs. In tailbud-stage embryos fhl3 is detected in the NCCs migrating towards the branchial arches with a stronger expression in the hyoid stream, compared to twist1 which labels all migrating NCCs. In tadpoles, fhl3 is observed in branchial arches, notochord and somites. In summary, fhl3 was detected in two key tissues involved in NC formation: in the dorsal mesoderm, at the time of NB induction by the underlying paraxial mesoderm, i.e. upstream of NC specification, and later on, in the premigratory, migrating and differentiating cranial NCCs themselves.
Interestingly, fhl3 expression partly overlapped with pax3 which is essential for NC induction in the ectoderm, consistent with the identification of fhl3 as a putative target of Pax3 (Bae et al., 2014, and our unpublished data) . To test the role of Pax3 in fhl3 induction in NC, we either increased or depleted Pax3 unilaterally, using mRNA injections or a validated morpholino oligonucleotide (MO, Monsoro-Burq et al., 2005) . Fhl3 expression was modestly expanded upon Pax3 gain of function and eliminated after Pax3 depletion in vivo ( Figure 1B,   S3 ).
Fhl3 is essential for neural border specification in gastrulas and neural crest induction in neurulas
To assess its developmental function in vivo, we depleted Fhl3 on one side of frog embryos using either a translation-blocking MO, or a splice-blocking MO or CRISPR/cas9mediated fhl3 mutation (Figures 1C-H, S2-S3). MO specificity and lack of toxicity were assessed by a phenotype rescue with human FHL3, also indicating the evolutive conservation of the protein's function ( Figure 1C ). After Fhl3 depletion, NB markers tfap2a, pax3 and msx1 were severely downregulated on the injected side of late gastrulas, while others such as zic1 were unchanged or even upregulated ( Figure 1D ). Expression of the NP marker sox2 was expanded. This demonstrated that fhl3 morphant NB tissue was present but mispatterned.
Expression of the pan-mesoderm marker tbxt (xbra) or of the paraxial mesoderm marker myod were unaffected indicating globally normal mesoderm formation. These results indicate that Fhl3 does not affect the global formation of dorsal mesoderm and ectoderm during gastrulation but is essential for NB early patterning.
During neurulation, Fhl3 knockdown caused the downregulation of all premigratory NC markers tested: snai2, foxd3, twist1 and sox10 ( Figure 1E ). Instead, sox2 expansion indicated that the NP was enlarged, at the expense of NC and non-neural ectoderm (marked by epidermal keratin epK). Transverse sections confirmed the lateral expansion of the neural tissue (sox2) and the lateral shift of the reduced snai2 territory ( Figure 1F ). At tailbud stage, Fhl3 morphant cranial NCC migration into the pharyngeal arches was markedly reduced (labeled by twist1 expression, Figure 1G ), resulting in severe alterations of craniofacial skeleton differentiation ( Figure 1H ). In particular, the trabeculae cranii derived from the mandibular and hyoid arches were missing on the injected side and branchial arches were reduced. Together, these results indicate that during NC formation, Fhl3 is necessary for NB and NC induction and that the early NC developmental defects caused by Fhl3 depletion were not compensated at later stages of NC differentiation.
Fhl3 controls BMP signaling in the paraxial mesoderm
The altered gene patterns observed above after Fhl3 depletion could result from abnormal signaling events in the early NB/NC-GRN. Lower BMP signaling could expand the neural plate and shift/reduce the NB laterally. During NB induction, zic1 expression is triggered by low BMP signaling, while tfap2a, pax3, and msx1 are activated by high WNT signaling (De Crozé et al., 2011; Mizuseki et al., 1998) . Thus, low BMP and low WNT signals could result in the observed gene pattern deregulations. Since Fhl3 was previously shown to mediate TGFb signaling in cancer cells, we asked whether the early loss of Fhl3 affects BMP activity in the prospective paraxial mesoderm. A BMP signaling reporter driving luciferase expression was injected into embryos together with fhl3 MO. The DLMZ was dissected out of early gastrulas ( Figure 2A ). Luciferase activity was significantly reduced in fhl3 morphant DLMZ compared to controls ( Figure 2B ). Furthermore, phosphorylation of R-Smad1-5-8 (pSmad1/5/8) was strongly decreased in fhl3 morphant DLMZ ( Figure 2C ). Both results demonstrate that Fhl3 depletion strongly lowers BMP signaling in the paraxial mesoderm.
To investigate the impact of Fhl3 depletion on the NB-NC-inducing ability of the paraxial mesoderm, we used a classical assay in X. laevis embryos (Bonstein et al., 1998) : the recombination of a DLMZ, dissected from an early gastrula, with a fragment of pluripotent blastocoel roof ectoderm dissected from a late blastula (animal cap, AC) ( Figure 2D ). When compared to control DLMZ, fhl3 morphant DLMZ was unable to activate NB and NC markers pax3, snai2 and sox10. Moreover, to test if the altered BMP signaling observed in the morphant mesoderm was causing its lack of inducing activity, we attempted a phenotype rescue by coinjecting fhl3 MO with a constitutively active form of Smad1 (Smad1 3SD) or of BmpR1 (caBMPR). In this case, the co-injected DLMZ recovered ability to activate pax3 and snai2 expression albeit with lower efficiency compared to uninjected control. These results demonstrate that Fhl3 mesodermal function is essential for NC induction in the ectoderm by the paraxial mesoderm, at least partly by promoting BMP signaling.
Fhl3 controls vertical Wnt8 signaling acting between paraxial mesoderm and ectoderm during NC induction.
Wnts and FGFs from the paraxial mesoderm are crucial for inducing the NC. Therefore, we quantified the expression of dusp5, a FGF-responsive gene, and axin2, a readout for canonical WNT signaling, in mesoderm-ectoderm recombinants ( Figure 2E ). Axin2 expression, but not dusp5 levels, was reduced in the fhl3 morphant recombinants suggesting altered WNT activity and normal FGF function. To confirm that Fhl3 depletion in the mesoderm resulted in altered canonical WNT signaling specifically in the ectoderm, we injected a WNT/bcatenin signaling reporter vector (TOPFLASH) into the ectoderm only and juxtaposed it to a DLMZ dissected either from uninjected or from fhl3 morphant embryo. Compared to the control situation, the ectoderm combined to morphant mesoderm showed a significantly decreased response to WNT signaling ( Figure 2F ). These results thus show that the levels of WNT activity in the ectoderm depend on Fhl3 function in the DLMZ.
To test if the decreased WNT signaling observed in the ectoderm following Fhl3 mesodermal depletion was sufficient to explain the lack of NC induction in the ectoderm, we implemented a phenotype rescue using either an inducible form of activated TCF3 or wnt8 gain-of-function, injected in the ectoderm only ( Figure 2G ). When uninduced ectoderm was juxtaposed to Fhl3-depleted DLMZ, pax3 and snai2 expression levels were low, as observed with uninjected ectoderm previously. However, upon induction of TCF3 or increased Wnt8 expression in the ectoderm, pax3 and snai2 levels were fully recovered. Together, these results demonstrate that Fhl3 early function in the paraxial mesoderm is critical for its ability to activate the canonical WNT signaling at levels required for NC induction in the ectoderm.
During neurulation, Fhl3 is necessary for NC induction by neural border specifiers and controls both BMP and WNT signaling levels in the ectoderm
During the subsequent steps of the NB/NC-GRN, fhl3 is activated by Pax3 in the NC cells ( Figure 1 ). In order to separate the roles of fhl3 in NC formation within the ectoderm from its functions in the mesoderm, we have used direct NC induction in pluripotent blastocoel roof ectoderm (induced NC, iNC) by co-injecting calibrated levels of Pax3 and Zic1, a combination of two transcription factors necessary and sufficient for NC induction and development from the early ectoderm (Milet et al., 2013, Figure 3A ). Compared to control iNC, co-injecting fhl3 MO prevents the activation of NC markers snai2 and sox10 suggesting that Fhl3 is also required for premigratory NC specification downstream of NB regulators ( Figure 3B ).
Moreover, Pax3 displays a positive autoregulatory loop in the ectoderm important for pax3 maintenance in the NB (Plouhinec et al., 2014) . Fhl3 morphant ectoderm seems defective for this autoregulation, since pax3 expression is decreased as well.
Next, we tested whether Fhl3 depletion in iNC affected BMP and WNT signaling as observed in the mesoderm. When either the BMP or the WNT signaling reporters were coinjected with Pax3 mRNA, Zic1 mRNA and fhl3 MO, the luciferase activity was severely reduced compared to signal in control iNC ( Figure 3C ). Finally, co-injection of either caSmad1 or wnt8, in fhl3 morphant iNC were sufficient to rescue snai2 and pax3 expression ( Figure 3D ).
Altogether, these data indicate that, during neurula-stage steps of the NC-GRN, Fhl3 promotes both BMP and WNT signaling in the ectoderm and that this regulation is necessary to achieve NC induction.
Smad1 and Fhl3 directly bind wnt8 promoter
The parallels between BMP activity and WNT signaling observed in the series of results described above both in the mesoderm and in the ectoderm during NC development, led us to hypothesize that Fhl3 could mediate a cross-talk between the two signaling pathways. In Fhl3 morphant mesoderm, we observed diminished expression of wnt8 and WNT-responsive gene myf5 on the injected side ( Figures 4A, S2C ). In addition, the decreased pSmad1/5/8 levels suggested a post-translational regulation downstream of BMPR ( Figure 2C ), while the decreased wnt8 expression suggested a transcriptional regulation. In line with this hypothesis, we found Smad binding elements in the proximal wnt8 promoter region (BS1-2, Figure 4A ). To examine Smad1 occupancy at these sites, we injected tracing amounts of FLAG-tagged Smad1 in whole embryos and used an anti-FLAG antibody at late gastrula stage for in vivo chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR): strong Smad1 occupancy was detected at both sites (binding to BMP-responsive gene ventx1 serves as a positive control, Figure S2F ). When the embryos were injected with FLAG-tagged Fhl3, clear Fhl3 binding was observed on the same BS1-2 on wnt8 promoter, showing that Smad1 and Fhl3 are likely engaged together in the transcriptional complex regulating wnt8 expression ( Figure 4B ). When BMP signaling was decreased by injecting the extracellular BMP antagonist Noggin in whole embryos, Fhl3 signal was reduced, showing that Fhl3 specifically binds these sequences in response to active BMP signaling ( Figure 4C ). Finally, after Fhl3 depletion either in the mesoderm or in the NC-induced ectoderm, gain-of-function of caSmad1 or caBMPR restores wnt8 and axin2 expression, indicating that the function of Fhl3 in the NC-GRN is to enhance Smad1 activity which in turn up-regulates wnt8 expression ( Figure 4D ). In sum, Fhl3 is a novel and key coordinator of BMP/Smad1 and WNT/b-catenin signaling that tunes the levels of activity of these pathways in dorsal tissues to trigger NC induction during the two first steps of the NC-GRN ( Figure 4E ).
Discussion.
Early Figure 4E ). In the absence of Fhl3, the initial events of mesoderm patterning are intact (tissue morphology, tbxt expression, Figure 1 ) but the downstream mesoderm signaling activity during gastrulation is impaired (BMP, WNT, Figure 2 ). As a result, WNT-responsive NB specifiers are not activated and NB ectoderm induction fails and the neural plate is expanded, ultimately preventing NC development ( Figure   1, 4) . This is the first demonstration of a molecular link coordinating BMP and WNT signaling at the root of the NB/NC-GRN during gastrulation. Furthermore, during neurulation, WNT , 2015) . In particular, snai2 is directly activated by both Pax3 and WNT signals (Plouhinec et al., 2014; Vallin et al., 2001) . Here we show that Pax3 also activates fhl3 in the prospective NC, and that Fhl3 promotes WNT signaling in a Smad-dependent manner in premigratory NC cells (Figures 1, 3, 4D ). This creates a positive amplification loop, encoded within the NC-GRN and coordinating both secreted and transcriptional NC inducers to achieve a robust NC specification ( Figure 4F ). To conclude, Fhl3 is a novel regulator of BMP signaling, modulating the spatial and temporal response to BMPs in a germ layer-specific manner, and coordinating BMP and WNT signaling at several stages of NC development. In the global view of early development, our findings highlight how regional patterns are achieved in vertebrate embryos following the initial dorsal-ventral patterning: the cooperation between dorsal (Fhl3) and ventral (BMP) cues positions a secondary signaling center in the paraxial mesoderm, 
Materials and Methods
Sub-cloning of Xenopus laevis fhl3 cDNA
An fhl3 expression vector was obtained by amplifying the full-length fhl3 cDNA by PCR from late neurula stage whole embryo cDNA, and inserting it into pGEM-T Easy (Promega) by TA cloning. The insert was then subcloned into pCS107 (NotI site). Fhl3 PCR primers are listed in Table S1 .
Xenopus embryos manipulations
Ovulation, in vitro fertilization and embryo culture were performed using standard methods described in Sive et al., (2000) . Embryos were staged according to P.D. Nieuwkoop and J. Faber (1995) . All procedures were performed according to the European animal use and care law (animal care and housing approval license #C91-471-108, Direction Départementale de Protection de la Population, Courcouronnes, France).
In vivo gene depletion, gain of function and rescue experiments
For knockdown experiments, two antisense morpholino oligonucleotide (MO) were synthesized to block fhl3 translation or splicing (Gene Tools, In each case, blastomeres were co-injected with b-gal mRNA (250pg) or GFP mRNA (200pg) to identify the injected side (marked by a red asterisk).
For CRIPSR/cas9 experiments, one sgRNA primer was synthesized at the Cold Spring Harbor Laboratory during the Cell and Developmental Biology of Xenopus Course. We synthesized fhl3 gRNA using MEGAshortscript T7 transcription kit (Table S1 ). Cas9 protein (2.5 ng) and
fhl3 sgRNA (300 pg) were co-injected into one blastomere of two-cell stage embryos.
Neural crest induction in mesoderm/ectoderm recombination assay
To recombine mesoderm at NC-inducing stage to responsive "naive" ectoderm, a heterochronic recombination was used (Bonstein et al., 1998) . Animal caps were dissected out from blastula stage embryos (stage 9). Simultaneously, dorsal-lateral marginal zone (DLMZ) explants were dissected out from gastrula stage embryos (stage 10.5), defined when a faint pigment line is formed at the dorsal lip by the involuting cells. Recombinants were formed by juxtaposing the two tissues to one another, and cultured in ¾ NAM medium (Slack and Forman, 1980) until sibling embryos reached the late neurula stage 18.
Direct neural crest induction (iNC)
Animal cap ectoderm is a source of pluripotent cells that respond to Pax3/Zic1 activation by a complete NC development (Milet et al., 2013) . For such iNC (induced Neural Crest) assays, were co-injected with pax3-GR mRNA, zic1-GR mRNA and fhl3 MO. Animal cap explants were dissected out at stage 9 and dexamethasone (or its solvent ethanol as a control) was added at stage 10.5. Explants were lysed at stage 18.
Whole mount in situ hybridization (WISH) and sectioning
Embryos were stained using a fast whole-mount in situ hybridization protocol (Monsoro-Burq, 2007 Figure 1D ). The blastopore of late gastrulas is marked by a white dashed circlet. The dotted lines in Figure 1E indicate the midline. Tailbud stage embryos are seen in side views, anterior to the left. A sagittal view of a dissected late gastrula embryo is shown in the top right panel in Figure 1A . Mid-and late neurula embryos were embedded in paraffin and 12-µm-thick microtome transverse sections were cut (Figure 1 A, F).
Cartilage staining
Stage 45 tadpoles were fixed, dehydrated and stained in Alcian Blue for 24 hours. After several washes in ethanol until no blue stain is released, embryos were rehydrated, cleared with 4% KOH and transferred into graded glycerol solution in 2% KOH. Finally, ventral head cartilage was dissected. Whole tadpoles are shown from the dorsal side, anterior to the top and the matching dissected cartilages are viewed from the ventral side, anterior to the top ( Figure 1H ).
Luciferase assay
For BMP reporter assay ( Figure 2B ), Renilla DNA (pRL; Promega, 25 pg) and BMP reporter DNA (50 pg) were co-injected into both blastomeres at two-cell stage with or without 15 ng fhl3
MO. Twenty DLMZ explants were dissected at stage 10.5, grown in ¾ NAM, and lysed in 60 µl of Passive lysis buffer (Promega) at stage 12.5.
For WNT reporter assay in ectoderm/mesoderm recombinants ( Figure 2F ), Renilla DNA (25 pg) and WNT reporter DNA (TOPFLASH, 50 pg) were co-injected into both blastomeres at two-cell stage. Animal cap (ectoderm) explants were dissected at stage 9 and juxtaposed to control or Fhl3 depleted DLMZ. 15 recombinant explants were lysed in 60 µl Passive lysis buffer at stage 18.
For BMP and WNT reporter assays in iNC ( Figure 3C ), Renilla DNA (25 pg), pax3-GR mRNA (35 pg) and zic1-GR mRNA (72 pg) were co-injected with either BMP reporter DNA (50 pg) or WNT reporter DNA (50 pg) into both blastomeres at two-cell stage with or without 15 ng of fhl3 MO. Twenty animal cap (ectoderm) explants were dissected out from stage 9 embryos and lysed in 60 µl of Passive lysis buffer at stage 18.
In all assays, Firefly and Renilla luciferase activities were measured using the Dual-Glo Luciferase Assay System (Promega).
qRT-PCR
Total RNA was extracted using Phenol/Chloroform/Isoamyl Alcohol from Xenopus laevis embryos or tissue explants at late neurula stage (stage 18). We used M-MLV reverse transcriptase for reverse transcription and SYBR Green mix (BIO-RAD) for quantitative RT-PCR. Results were normalized against the reference genes odc and ef1a. For primers sequences see Table S1 .
Chromatin immunoprecipitation (ChIP)
Embryos were injected in both blastomeres at two-cell stage with mRNA encoding FLAG-Smad1 (200 pg) and FLAG-Fhl3 cDNA separately (200 pg) or FLAG-Fhl3 cDNA with noggin mRNA (25 pg). Injected embryos were collected at late gastrula stage (stage 12, 100 embryos/sample) and processed according to (Wills et al., 2014) . Sonication was performed using a 3.2 mm tapered microtip for 13 mm horn (Branson 450 sonicator). Anti-FLAG antibodies (42 µg) coupled to magnetic beads were added to the chromatin. Quantitative PCR was performed with immunoprecipitated fragmented chromatin using wnt8 and ventx1.1 promoter region primers. qPCR results were normalized to ef1a and input. Primers and FLAG antibody are listed in Table S1 .
Western blot detection of phospho Smads
10 to 15 DLMZ explants were dissected at stage 10.5, lysed when sibling embryos reached stage 12.5 in presence of phosphatase inhibitor (PhosphoSTOP, Roche) and protease inhibitors (Sigma) and analyzed by standard western blotting. ECL signal was quantified using
ImageJ. Antibodies are listed in table S1.
Statistical analysis, imaging and image processing
All experiments were performed at least in biological triplicates (except the rescue experiment shown in Figure 2D , the Fhl3-FLAG + noggin ChIP experiment ( Figure 4C ) and axin2 and wnt8 rescue experiment in Figure 4D , which were performed in biological duplicates). Each dot on the graphs represents one independent experiment. Examples of embryos with the most frequent phenotypes are shown. We used Prism for statistical analysis, error bars represent S.E.M. and Student's t-test was used to determine statistical significance (*p<0.05; **p<0.01; ***p<0.001, ns: not significant). Images were taken using a Lumar V12 Binocular microscope equipped with bright field or fluorescent filters and color camera (Zeiss), and were processed using Photoshop. 
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